Valuation: Albert David Limited

Market Cap 3.35B 35.13M 30.72M 28.34M 26.17M 49.67M 50.5M 339M 133M 1.65B 132M 129M 5.67B P/E 2024
8.14x
P/E 2025 26.9x
Enterprise Value 1.04B 10.87M 9.51M 8.77M 8.1M 15.37M 15.63M 105M 41.15M 511M 40.81M 39.93M 1.76B EV / Sales 2024
0.92x
EV / Sales 2025 0.67x
Free-Float
35.96%
Yield 2024
1.07%
Yield 2025 0.62%
1 week-3.69%
Current month-0.98%
1 month-0.39%
3 months-5.52%
6 months-5.14%
Current year-6.22%
1 week 689.3
Extreme 689.3
714
1 month 689.3
Extreme 689.3
739
Current year 581.3
Extreme 581.3
819.9
1 year 581.3
Extreme 581.3
945.85
3 years 581.3
Extreme 581.3
1,752.95
5 years 485.4
Extreme 485.4
1,752.95
10 years 255
Extreme 255
1,752.95
Manager TitleAgeSince
Chief Executive Officer 52 11/05/2026
Director of Finance/CFO - 30/11/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 13/11/2024
Chairman 73 29/12/2009
Director/Board Member 68 30/03/2014
Date Insider Type Main position Quantity % Market Cap.
26/02/25
Kothari Phytochemicals & Industries Ltd.
BuyCompany 6,000 0.1051%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.69%-23.25%+4.72% 41.53M
-0.17%+1.61%+15.76%+80.51% 48.69B
+1.04%-1.02%+67.19%+116.18% 36.38B
-0.13%-1.29%-3.07%+40.05% 12.19B
-0.71%+0.89%+17.48%+96.77% 12.04B
-0.76%+0.38%+31.49%+124.03% 9.04B
+0.75%-0.82%+18.53%+42.99% 7.09B
-0.86%+0.37%+50.57%-3.02% 7.06B
+0.69%+3.25%+4.67%+240.43% 6.75B
+5.45%-7.36%-17.51%+14.39% 6.1B
Average +0.53%-0.75%+16.19%+75.70% 14.54B
Weighted average by Cap. +0.34%+0.09%+28.07%+88.84%

Financials

2024 2025
Net sales 3.62B 38M 33.24M 30.66M 28.32M 53.73M 54.64M 366M 144M 1.79B 143M 140M 6.14B 3.46B 36.25M 31.71M 29.25M 27.01M 51.26M 52.12M 349M 137M 1.7B 136M 133M 5.86B
Net income 754M 7.91M 6.92M 6.38M 5.89M 11.18M 11.37M 76.23M 29.94M 372M 29.69M 29.05M 1.28B 172M 1.8M 1.58M 1.46M 1.34M 2.55M 2.59M 17.39M 6.83M 84.74M 6.77M 6.62M 291M
Net Debt -2.82B -29.56M -25.85M -23.85M -22.03M -41.79M -42.49M -285M -112M -1.39B -111M -109M -4.77B -2.31B -24.26M -21.22M -19.57M -18.07M -34.3M -34.87M -234M -91.82M -1.14B -91.07M -89.09M -3.92B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,805
Date Price Change Volume
10/07/26 ₹694.00 0.00% 78
09/07/26 ₹694.00 +0.68% 5
08/07/26 ₹689.30 -2.21% 223
06/07/26 ₹704.85 -2.19% 140
03/07/26 ₹720.60 +1.77% 20
  1. Stock Market
  2. Stocks
  3. ALBERTDAVD Stock